Next Article in Journal
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
Next Article in Special Issue
Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
Previous Article in Journal
Racial and Ethnic Diversity in SARS-CoV-2 Vaccine Clinical Trials Conducted in the United States
Previous Article in Special Issue
Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination
 
 
Brief Report

Article Versions Notes

Vaccines 2022, 10(2), 291; https://doi.org/10.3390/vaccines10020291
Action Date Notes Link
article pdf uploaded. 14 February 2022 16:15 CET Version of Record https://www.mdpi.com/2076-393X/10/2/291/pdf-vor
article supplementary file uploaded. 14 February 2022 16:15 CET - https://www.mdpi.com/2076-393X/10/2/291#supplementary
article xml file uploaded 16 February 2022 03:26 CET Original file -
article xml uploaded. 16 February 2022 03:26 CET Update https://www.mdpi.com/2076-393X/10/2/291/xml
article pdf uploaded. 16 February 2022 03:26 CET Updated version of record https://www.mdpi.com/2076-393X/10/2/291/pdf
article html file updated 16 February 2022 03:27 CET Original file -
article html file updated 16 February 2022 10:21 CET Update -
article html file updated 31 July 2022 17:59 CEST Update https://www.mdpi.com/2076-393X/10/2/291/html
Back to TopTop